Purchase Order 36C24225P1502
Award Date 9/11/25
Potential Completion Date 11/1/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15205, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for the provision of TARPEYO medication, valued at $10,896.98. This contract, awarded on November 4, 2025, carries an ultimate completion date of December 31, 2025, and includes no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania, where the prime contractor is...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
- Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, was awarded a firm fixed-price purchase order valued at $10,896.98 by Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs. The award, dated October 30, 2025, covers the supply of Tarpeyo 4mg (budesonide), a specialty pharmaceutical product, with performance occurring in Pittsburgh, Pennsylvania and ultimate completion targeted for November 30, 2025. No set-aside...
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of the prescription medication Tarpeyo 4mg capsules to VA facilities within Veterans Integrated Service Network 2. The contract has a total ceiling value of $10,638.00 and runs through March 20, 2025. There is no set-aside designation associated...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business. The contract, valued at $1,326,625.26, is for the supply of the pharmaceutical drug pantoprazole to all VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The contract does not have a set-aside designation and has an ultimate completion date of February 26, 2016. Tri-Pharma, Inc. is a Subchapter S...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to United Therapeutics Corp for the supply of Tyvaso 64 mcg kits, a specialized pharmaceutical product used to treat pulmonary arterial hypertension in veterans. This firm-fixed-price delivery order, valued at $16,514.15, was awarded on August 21, 2025, with an ultimate completion date of August 26, 2025. The contract does not include a set-aside designation. United Therapeutics, a...